Rep. Jamie Raskin subtly roasts Madison Cawthorn during House marijuana vote

The House of Representatives on Friday passed a bill decriminalizing marijuana on a federal level, The New York Times reports, noting the bill is likely doomed in the Senate.
The Marijuana Opportunity Reinvestment and Expungement Act passed 220-204, with Republican Reps. Matt Gaetz (Fl.), Brian Mast (Fl.), and Tom McClintock (Calif.) joining in with the Democrats, the Times notes. The bill removes cannabis from the federal government's list of controlled substances, levies an 8 percent tax on marijuana products, allows some cannabis-related convictions to be expunged, and urges "sentencing reviews at the federal and state levels," the Times notes. Small Business Administration Loans would also be made available to cannabis businesses.
Notably, when speaking during Friday's vote, Rep. Jamie Raskin (D-Md.) quite comically called out a separate drug-related issue, this one involving freshman lawmaker Rep. Madison Cawthorn (R-N.C.) and his claims of Washington, D.C. orgies and cocaine use.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
After calling into question the GOP's "paranoid tropes" of marijuana use, Raskin remarked that "our party is not for the kind of cocaine-fueled orgies that a freshman Republican representative bragged about this week," he said, alluding to Cawthorn. "But we do understand that their marijuana prohibition laws don't work for our people."
In the controversial remarks to which Raskin is referring, Cawthorn had claimed he'd been invited to orgies at the homes of D.C. insiders and watched leaders in the anti-drug movement doing key bumps of cocaine. The North Carolina lawmaker has since admitted his comments were exaggerated.
Afterward, Raskin's jab got a warm reception online.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Brigid Kennedy worked at The Week from 2021 to 2023 as a staff writer, junior editor and then story editor, with an interest in U.S. politics, the economy and the music industry.
-
Panspermia: the theory that life was sent to Earth by aliens
Under The Radar New findings have resurfaced an old, controversial idea
-
What's a bridge loan and how could it make buying your next home possible?
The Explainer This type of loan has both pros and cons
-
The Week contest: Phone risk
Puzzles and Quizzes
-
House posts lewd Epstein note attributed to Trump
Speed Read The estate of Jeffrey Epstein turned over the infamous 2003 birthday note from President Donald Trump
-
Supreme Court allows 'roving' race-tied ICE raids
Speed Read The court paused a federal judge's order barring agents from detaining suspected undocumented immigrants in LA based on race
-
South Korea to fetch workers detained in Georgia raid
Speed Read More than 300 South Korean workers detained in an immigration raid at a Hyundai plant will be released
-
DC sues Trump to end Guard 'occupation'
Speed Read D.C. Attorney General Brian Schwalb argues that the unsolicited military presence violates the law
-
RFK Jr. faces bipartisan heat in Senate hearing
Speed Read The health secretary defended his leadership amid CDC turmoil and deflected questions about the restricted availability of vaccines
-
White House defends boat strike as legal doubts mount
Speed Read Experts say there was no legal justification for killing 11 alleged drug-traffickers
-
Epstein accusers urge full file release, hint at own list
speed read A rally was organized by Reps. Ro Khanna and Thomas Massie, who are hoping to force a vote on their Epstein Files Transparency Act
-
Court hands Harvard a win in Trump funding battle
Speed Read The Trump administration was ordered to restore Harvard's $2 billion in research grants